These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


131 related items for PubMed ID: 10809518

  • 1. Methadone dose and retention during treatment of heroin addicts with Axis I psychiatric comorbidity.
    Maremmani I, Zolesi O, Aglietti M, Marini G, Tagliamonte A, Shinderman M, Maxwell S.
    J Addict Dis; 2000; 19(2):29-41. PubMed ID: 10809518
    [Abstract] [Full Text] [Related]

  • 2. Long-term outcomes of treatment-resistant heroin addicts with and without DSM-IV axis I psychiatric comorbidity (dual diagnosis).
    Maremmani I, Pacini M, Lubrano S, Perugi G, Tagliamonte A, Pani PP, Gerra G, Shinderman M.
    Eur Addict Res; 2008; 14(3):134-42. PubMed ID: 18552489
    [Abstract] [Full Text] [Related]

  • 3. Effects of psychiatric comorbidity on treatment outcome in patients undergoing diamorphine or methadone maintenance treatment.
    Schäfer I, Eiroa-Orosa FJ, Verthein U, Dilg C, Haasen C, Reimer J.
    Psychopathology; 2010; 43(2):88-95. PubMed ID: 20068379
    [Abstract] [Full Text] [Related]

  • 4. Psychiatric comorbidity in methadone maintained patients.
    Mason BJ, Kocsis JH, Melia D, Khuri ET, Sweeney J, Wells A, Borg L, Millman RB, Kreek MJ.
    J Addict Dis; 1998; 17(3):75-89. PubMed ID: 9789161
    [Abstract] [Full Text] [Related]

  • 5. [Co-morbidity: psychiatric disorder of opiate addicts at entry into heroin-assisted treatment].
    Frei A, Rehm J, Arbeitsgruppe HeGeBe Doppeldiagnosen.
    Psychiatr Prax; 2002 Jul; 29(5):251-7. PubMed ID: 12101491
    [Abstract] [Full Text] [Related]

  • 6. Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment.
    Astals M, Domingo-Salvany A, Buenaventura CC, Tato J, Vazquez JM, Martín-Santos R, Torrens M.
    Subst Use Misuse; 2008 Jul; 43(5):612-32. PubMed ID: 18393080
    [Abstract] [Full Text] [Related]

  • 7. Psychiatric comorbidity and gender difference among treatment-seeking heroin abusers in Taiwan.
    Chiang SC, Chan HY, Chang YY, Sun HJ, Chen WJ, Chen CK.
    Psychiatry Clin Neurosci; 2007 Feb; 61(1):105-11. PubMed ID: 17239047
    [Abstract] [Full Text] [Related]

  • 8. Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance.
    Ngo HT, Tait RJ, Hulse GK.
    J Psychopharmacol; 2011 Jun; 25(6):774-82. PubMed ID: 20360157
    [Abstract] [Full Text] [Related]

  • 9. Psychiatric comorbidity and additional abuse of drugs in maintenance treatment with L- and D,L-methadone.
    Wedekind D, Jacobs S, Karg I, Luedecke C, Schneider U, Cimander K, Baumann P, Ruether E, Poser W, Havemann-Reinecke U.
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):390-9. PubMed ID: 20218800
    [Abstract] [Full Text] [Related]

  • 10. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G, Saenz E, Busse A, Maremmani I, Ciccocioppo R, Zaimovic A, Gerra ML, Amore M, Manfredini M, Donnini C, Somaini L.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar 30; 35(2):483-9. PubMed ID: 21147192
    [Abstract] [Full Text] [Related]

  • 11. [Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature].
    Laqueille X, Launay C, Dervaux A, Kanit M.
    Encephale; 2009 Jun 30; 35(3):220-5. PubMed ID: 19540407
    [Abstract] [Full Text] [Related]

  • 12. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
    Maremmani I, Pani PP, Pacini M, Perugi G.
    J Subst Abuse Treat; 2007 Jul 30; 33(1):91-8. PubMed ID: 17588494
    [Abstract] [Full Text] [Related]

  • 13. Chronic cannabis use does not affect the normalization of hypothalamic-pituitary-adrenal (HPA) axis induced by methadone in heroin addicts.
    Nava F, Manzato E, Lucchini A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1089-94. PubMed ID: 17466429
    [Abstract] [Full Text] [Related]

  • 14. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A, Casarella J, Amar R, Vayalapalli S, Drexler K.
    J Psychiatr Pract; 2009 May 30; 15(3):227-34. PubMed ID: 19461397
    [Abstract] [Full Text] [Related]

  • 15. The impact of benzodiazepine use on methadone maintenance treatment outcomes.
    Brands B, Blake J, Marsh DC, Sproule B, Jeyapalan R, Li S.
    J Addict Dis; 2008 May 30; 27(3):37-48. PubMed ID: 18956528
    [Abstract] [Full Text] [Related]

  • 16. Alcohol and cocaine use and abuse among opioid addicts engaged in a methadone maintenance treatment program.
    Maremmani I, Pani PP, Mellini A, Pacini M, Marini G, Lovrecic M, Perugi G, Shinderman M.
    J Addict Dis; 2007 May 30; 26(1):61-70. PubMed ID: 17439869
    [Abstract] [Full Text] [Related]

  • 17. Use of street methadone in italian heroin addicts presenting for opioid agonist treatment.
    Maremmani I, Pacini M, Pani PP, Popovic D, Romano A, Maremmani AG, Deltito J, Perugi G.
    J Addict Dis; 2009 Oct 30; 28(4):382-8. PubMed ID: 20155607
    [Abstract] [Full Text] [Related]

  • 18. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P, Guglielmino L, Marzorati P, Silenzio R, De Chiara M, Corrado F, Cocchi L, Cozzolino E.
    J Subst Abuse Treat; 2006 Jul 30; 31(1):3-7. PubMed ID: 16814005
    [Abstract] [Full Text] [Related]

  • 19. Experiences with an outpatient relapse program (community reinforcement approach) combined with naltrexone in the treatment of opioid-dependence: effect on addictive behaviors and the predictive value of psychiatric comorbidity.
    Roozen HG, Kerkhof AJ, van den Brink W.
    Eur Addict Res; 2003 Apr 30; 9(2):53-8. PubMed ID: 12644730
    [Abstract] [Full Text] [Related]

  • 20. [Influence of psychiatric disorders in the effectiveness of a long-term methadone maintenance treatment].
    Fernández Miranda J, González García-Portilla M, Sáiz Martínez P, Gutiérrez Cienfuegos E, Bobes García J.
    Actas Esp Psiquiatr; 2001 Apr 30; 29(4):228-32. PubMed ID: 11470057
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.